Source:
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p8-29, 22p
Publication Date:
2023-06-02
Language:
English
Abstract
Abstract:
James O. Armitage, Omaha, NE, USA18:00-19:00THE BIG DEBATERoom AMOVING TARGETS IN LYMPHOMA TREATMENTChair: Emanuele Zucca, Bellinzona, CHSatellite symposium organized by the Foundation for the Institute of Oncology Research (IOR). YES Michael L. Wang, Houston, TX, USANO Martin Dreyling, Munich, DEDEBATE 2.Towards a cure for relapsing/refractory diffuse large B cell lymphoma: Bispecific antibodies better than CAR-T cells?. [Extracted from the article]
